Assertio Holdings, Inc. 8-K

What Happened
Assertio Holdings, Inc. (ASRT) filed an 8-K on May 8, 2026 (Regulation FD disclosure) to report that, on May 7, 2026, it reached a mutual agreement with Garda Therapeutics, Inc. to extend the deadline to commence the previously announced tender offer to purchase all outstanding shares of Assertio common stock to May 14, 2026. The extension is in connection with an Amended and Restated Agreement and Plan of Merger dated May 1, 2026 among Assertio, Garda and Audi Merger Sub, Inc. A press release dated May 8, 2026 announcing the extension was attached as Exhibit 99.1.

Key Details

• New tender offer commencement deadline: May 14, 2026 (agreement reached May 7, 2026).
• Merger agreement referenced: Amended and Restated Agreement and Plan of Merger dated May 1, 2026 between Assertio, Garda Therapeutics, and Audi Merger Sub.
• Disclosure filed under Regulation FD and press release included as Exhibit 99.1 to the 8-K (filed May 8, 2026).

Why It Matters
This notice delays the start of the tender offer tied to the announced merger, affecting the timetable for shareholders to tender their shares and for the transaction to proceed. Investors should monitor future SEC filings and company announcements for the tender offer materials, revised timelines, and any changes to deal terms.